These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

196 related articles for article (PubMed ID: 16859528)

  • 81. Plasma factors in severe early-onset preeclampsia do not substantially alter endothelial gene expression in vitro.
    Donker RB; Asgeirsdóttir SA; Gerbens F; van Pampus MG; Kallenberg CG; te Meerman GJ; Aarnoudse JG; Molema G
    J Soc Gynecol Investig; 2005 Feb; 12(2):98-106. PubMed ID: 15695104
    [TBL] [Abstract][Full Text] [Related]  

  • 82. What have we learned on pre, very early, and early systemic sclerosis microcirculatory pathophysiology? A scoping review.
    Caetano J; Rodrigues LM; Alves JD
    Autoimmun Rev; 2024 May; 23(5):103540. PubMed ID: 38604463
    [TBL] [Abstract][Full Text] [Related]  

  • 83. Vascular endothelial growth factor aggravates fibrosis and vasculopathy in experimental models of systemic sclerosis.
    Maurer B; Distler A; Suliman YA; Gay RE; Michel BA; Gay S; Distler JH; Distler O
    Ann Rheum Dis; 2014 Oct; 73(10):1880-7. PubMed ID: 23918036
    [TBL] [Abstract][Full Text] [Related]  

  • 84. Analysis of gene expression patterns in systemic sclerosis fibroblasts using RNA arbitrarily primed-polymerase chain reaction for differential display.
    Meyringer R; Neumann E; Judex M; Landthaler M; Kullmann F; Scholmerich J; Gay S; Tarner IH; Distler O; Müller-Ladner U
    J Rheumatol; 2007 Apr; 34(4):747-53. PubMed ID: 17407232
    [TBL] [Abstract][Full Text] [Related]  

  • 85. Lung tissues in patients with systemic sclerosis have gene expression patterns unique to pulmonary fibrosis and pulmonary hypertension.
    Hsu E; Shi H; Jordan RM; Lyons-Weiler J; Pilewski JM; Feghali-Bostwick CA
    Arthritis Rheum; 2011 Mar; 63(3):783-94. PubMed ID: 21360508
    [TBL] [Abstract][Full Text] [Related]  

  • 86. MicroRNA-130b regulates scleroderma fibrosis by targeting peroxisome proliferator-activated receptor γ.
    Luo H; Zhu H; Zhou B; Xiao X; Zuo X
    Mod Rheumatol; 2015 Jul; 25(4):595-602. PubMed ID: 25547017
    [TBL] [Abstract][Full Text] [Related]  

  • 87. Comprehensive investigation of disease-specific short peptides in sera from patients with systemic sclerosis: complement C3f-des-arginine, detected predominantly in systemic sclerosis sera, enhances proliferation of vascular endothelial cells.
    Xiang Y; Matsui T; Matsuo K; Shimada K; Tohma S; Nakamura H; Masuko K; Yudoh K; Nishioka K; Kato T
    Arthritis Rheum; 2007 Jun; 56(6):2018-30. PubMed ID: 17530642
    [TBL] [Abstract][Full Text] [Related]  

  • 88. Evidence for the involvement of SDF-1 and CXCR4 in the disruption of endothelial cell-branching morphogenesis and angiogenesis by TNF-alpha and IFN-gamma.
    Salvucci O; Basik M; Yao L; Bianchi R; Tosato G
    J Leukoc Biol; 2004 Jul; 76(1):217-26. PubMed ID: 15075355
    [TBL] [Abstract][Full Text] [Related]  

  • 89. Vascular leak is a central feature in the pathogenesis of systemic sclerosis.
    Frech TM; Revelo MP; Drakos SG; Murtaugh MA; Markewitz BA; Sawitzke AD; Li DY
    J Rheumatol; 2012 Jul; 39(7):1385-91. PubMed ID: 22660809
    [TBL] [Abstract][Full Text] [Related]  

  • 90. Endothelial CCR6 expression due to FLI1 deficiency contributes to vasculopathy associated with systemic sclerosis.
    Ikawa T; Miyagawa T; Fukui Y; Toyama S; Omatsu J; Awaji K; Norimatsu Y; Watanabe Y; Yoshizaki A; Sato S; Asano Y
    Arthritis Res Ther; 2021 Nov; 23(1):283. PubMed ID: 34774095
    [TBL] [Abstract][Full Text] [Related]  

  • 91. Automated Measurement of Microvascular Function Reveals Dysfunction in Systemic Sclerosis: A Cross-sectional Study.
    Machin DR; Gates PE; Vink H; Frech TM; Donato AJ
    J Rheumatol; 2017 Nov; 44(11):1603-1611. PubMed ID: 28916547
    [TBL] [Abstract][Full Text] [Related]  

  • 92. Bone marrow-derived mesenchymal stem cells from early diffuse systemic sclerosis exhibit a paracrine machinery and stimulate angiogenesis in vitro.
    Guiducci S; Manetti M; Romano E; Mazzanti B; Ceccarelli C; Dal Pozzo S; Milia AF; Bellando-Randone S; Fiori G; Conforti ML; Saccardi R; Ibba-Manneschi L; Matucci-Cerinic M
    Ann Rheum Dis; 2011 Nov; 70(11):2011-21. PubMed ID: 21821866
    [TBL] [Abstract][Full Text] [Related]  

  • 93. IL-17A induces endothelial inflammation in systemic sclerosis via the ERK signaling pathway.
    Xing X; Yang J; Yang X; Wei Y; Zhu L; Gao D; Li M
    PLoS One; 2013; 8(12):e85032. PubMed ID: 24376862
    [TBL] [Abstract][Full Text] [Related]  

  • 94. Platelets Induce Thymic Stromal Lymphopoietin Production by Endothelial Cells: Contribution to Fibrosis in Human Systemic Sclerosis.
    Truchetet ME; Demoures B; Eduardo Guimaraes J; Bertrand A; Laurent P; Jolivel V; Douchet I; Jacquemin C; Khoryati L; Duffau P; Lazaro E; Richez C; Seneschal J; Doutre MS; Pellegrin JL; Constans J; Schaeverbeke T; Blanco P; Contin-Bordes C;
    Arthritis Rheumatol; 2016 Nov; 68(11):2784-2794. PubMed ID: 27429171
    [TBL] [Abstract][Full Text] [Related]  

  • 95. Epigenetic repression of bone morphogenetic protein receptor II expression in scleroderma.
    Wang Y; Kahaleh B
    J Cell Mol Med; 2013 Oct; 17(10):1291-9. PubMed ID: 23859708
    [TBL] [Abstract][Full Text] [Related]  

  • 96. Gene profiling of scleroderma skin reveals robust signatures of disease that are imperfectly reflected in the transcript profiles of explanted fibroblasts.
    Gardner H; Shearstone JR; Bandaru R; Crowell T; Lynes M; Trojanowska M; Pannu J; Smith E; Jablonska S; Blaszczyk M; Tan FK; Mayes MD
    Arthritis Rheum; 2006 Jun; 54(6):1961-73. PubMed ID: 16736506
    [TBL] [Abstract][Full Text] [Related]  

  • 97. Enhanced angiogenic potency of monocytic endothelial progenitor cells in patients with systemic sclerosis.
    Yamaguchi Y; Okazaki Y; Seta N; Satoh T; Takahashi K; Ikezawa Z; Kuwana M
    Arthritis Res Ther; 2010; 12(6):R205. PubMed ID: 21050433
    [TBL] [Abstract][Full Text] [Related]  

  • 98. Dysregulated expression of MIG/CXCL9, IP-10/CXCL10 and CXCL16 and their receptors in systemic sclerosis.
    Rabquer BJ; Tsou PS; Hou Y; Thirunavukkarasu E; Haines GK; Impens AJ; Phillips K; Kahaleh B; Seibold JR; Koch AE
    Arthritis Res Ther; 2011 Feb; 13(1):R18. PubMed ID: 21303517
    [TBL] [Abstract][Full Text] [Related]  

  • 99. Enhanced expression of ephrins and thrombospondins in the dermis of patients with early diffuse systemic sclerosis: potential contribution to perturbed angiogenesis and fibrosis.
    Avouac J; Clemessy M; Distler JH; Gasc JM; Ruiz B; Vacher-Lavenu MC; Wipff J; Kahan A; Boileau C; Corvol P; Allanore Y
    Rheumatology (Oxford); 2011 Aug; 50(8):1494-504. PubMed ID: 21454305
    [TBL] [Abstract][Full Text] [Related]  

  • 100. Angiogenesis and vascular architecture in pheochromocytomas: distinctive traits in malignant tumors.
    Favier J; Plouin PF; Corvol P; Gasc JM
    Am J Pathol; 2002 Oct; 161(4):1235-46. PubMed ID: 12368197
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.